NEW YORK (GenomeWeb) -- French firm Skuldtech announced that it has changed its name to Acobiom.
Skuldtech, founded in 1999, historically has focused on genomic and transcriptomic biomarker discovery and diagnostic development. The name change signifies that the company is strategically shifting its focus toward personalized medicine.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
